To Evaluate the Immunogenicity and Safety of Two Different Immunization Schedules of Rabies Vaccine (Vero Cell)

Inclusion Criteria: * 9 to 65 years old healthy residents; * volunteered for the experiment and signed informed consent; * the subjects or their guardians can comply with the requirements of the clinical trial protocol; * have not received rabies vaccination at any time; * nearly six months has not been mammals bite, scratch; * not participating in clinical trials of other drugs; * No use of human immunoglobulin or other products in the past six months. Exclusion Criteria: First needle exclusion: * have allergies, convulsions, seizures, mental and nervous system, such as history, or family history of epilepsy; * Allergic to the main ingredient of the investigational vaccine; * known to people with poor immune function damage or the tumor, spleen; * Axillary temperature \>38.0℃ within 7 days due to acute febrile illness; * Patients with axillary body temperature \> 37.0℃; * Severe chronic diseases such as congenital malformation, developmental disorder or severe cardiovascular disease, diabetes mellitus, hypertension that cannot be stabilized by drugs, liver and kidney diseases, and malignant tumors; * patients with acute and chronic infectious diseases, active infections, severe asthma, infectious skin diseases; * pregnant and lactating women; Any circumstances that the investigator believes may affect the assessment of the trial. Subsequent needle exclusions: * any serious adverse event causally related to vaccination; * new findings that meet the "first dose exclusion…